Roman Sergeevich Knyazev
Director/Miembro de la Junta en PHARMSYNTHEZ .
Cargos activos de Roman Sergeevich Knyazev
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PHARMSYNTHEZ | Director/Miembro de la Junta | 20/02/2013 | - |
Nanolek Holding Ltd.
Nanolek Holding Ltd. BiotechnologyHealth Technology Nanolek Holding Ltd. operates as a holding Cypriot company that provides biotechnological services. | Director/Miembro de la Junta | 01/01/2013 | - |
Tsentr PETAR LLC | Director/Miembro de la Junta | 01/01/2012 | - |
Historial de carrera de Roman Sergeevich Knyazev
Antiguos cargos conocidos de Roman Sergeevich Knyazev.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
XENETIC BIOSCIENCES, INC. | Director/Miembro de la Junta | 30/04/2014 | 25/09/2019 |
Rusnano OJSC
Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Director de Inversiones | 01/01/2009 | 01/01/2014 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 29/01/2012 | 01/01/2013 |
Rusnano Management Co. LLC
Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Director de Inversiones | 01/01/2014 | - |
Lipoxen Technologies Ltd.
Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the company is based in London, UK. | Director/Miembro de la Junta | - | - |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Director/Miembro de la Junta | 01/01/2011 | - |
Formación de Roman Sergeevich Knyazev.
Moscow State University Lomonosov | Undergraduate Degree |
Estadísticas
Internacional
Rusia | 7 |
Reino Unido | 3 |
Estados Unidos | 2 |
Operativa
Director/Board Member | 7 |
Chief Investment Officer | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PHARMSYNTHEZ | Health Technology |
XENETIC BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Rusnano OJSC
Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Commercial Services |
Nanolek Holding Ltd.
Nanolek Holding Ltd. BiotechnologyHealth Technology Nanolek Holding Ltd. operates as a holding Cypriot company that provides biotechnological services. | Health Technology |
Lipoxen Technologies Ltd.
Lipoxen Technologies Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1997, Lipoxen Technologies Ltd. is a British company that specializes in product development in the pharmaceutical industry. Part of Xenetic Biosciences, Inc., the company is based in London, UK. | Health Technology |
Rusnano Management Co. LLC
Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Finance |
Tsentr PETAR LLC |